The impact of care pathways for exacerbation of Chronic Obstructive Pulmonary Disease: rationale and design of a cluster randomized controlled trial

Kris Vanhaecht, Walter Sermeus, Jan Peers, Cathy Lodewijckx, Svin Deneckere, Fabrizio Leigheb, Marc Decramer, Massimiliano Panella, EQCP Study Group, Kris Vanhaecht, Walter Sermeus, Jan Peers, Cathy Lodewijckx, Svin Deneckere, Martin Euwema, Marc Decramer, Steven Boonen, Massimiliano Panella, Fabrizio Leigheb, Wilma Cittaro, Domenico Tangolo, William Reddy, Antoinette Doocey, Paulo Alexandre Faria Boto, Rita Veloso Mendez, Kris Vanhaecht, Walter Sermeus, Jan Peers, Cathy Lodewijckx, Svin Deneckere, Fabrizio Leigheb, Marc Decramer, Massimiliano Panella, EQCP Study Group, Kris Vanhaecht, Walter Sermeus, Jan Peers, Cathy Lodewijckx, Svin Deneckere, Martin Euwema, Marc Decramer, Steven Boonen, Massimiliano Panella, Fabrizio Leigheb, Wilma Cittaro, Domenico Tangolo, William Reddy, Antoinette Doocey, Paulo Alexandre Faria Boto, Rita Veloso Mendez

Abstract

Background: Hospital treatment of chronic obstructive pulmonary disease (COPD) frequently does not follow published evidences. This lack of adherence can contribute to the high morbidity, mortality and readmissions rates. The European Quality of Care Pathway (EQCP) study on acute exacerbations of COPD (NTC00962468) is undertaken to determine how care pathways (CP) as complex intervention for hospital treatment of COPD affects care variability, adherence to evidence based key interventions and clinical outcomes.

Methods: An international cluster Randomized Controlled Trial (cRCT) will be performed in Belgium, Italy, Ireland and Portugal. Based on the power analysis, a sample of 40 hospital teams and 398 patients will be included in the study. In the control arm of the study, usual care will be provided. The experimental teams will implement a CP as complex intervention which will include three active components: a formative evaluation of the quality and organization of care, a set of evidence based key interventions, and support on the development and implementation of the CP. The main outcome will be six-month readmission rate. As a secondary endpoint a set of clinical outcome and performance indicators (including care process evaluation and team functioning indicators) will be measured in both groups.

Discussion: The EQCP study is the first international cRCT on care pathways. The design of the EQCP project is both a research study and a quality improvement project and will include a realistic evaluation framework including process analysis to further understand why and when CP can really work.

Trial registration number: NCT00962468.

Figures

Figure 1
Figure 1
The EQCP study design.
Figure 2
Figure 2
The EQCP complex intervention.

References

    1. Pearson SD, Goulart-Fisher D, Lee TH. Critical pathways as a strategy for improving care: problems and potential. Ann Intern Med. 1995;123(12):941–8.
    1. Campbell H, Hotchkiss R, Bradshaw N, Porteous M. Integrated care pathways. BMJ. 1998;316:133–7.
    1. Trowbridge R, Weingarten S. Critical Pathways. Chapter 52. Agency for Healthcare Research & Quality; 2001. Making health care safer, a critical analysis of patient safety practices. Ref Type: Internet Communication.
    1. Vanhaecht K, De Witte K, Sermeus W. The impact of clinical pathways on the organisation of care processes. Leuven: ACCO; 2007.
    1. Panella M, Marchisio S, Di Stanislao F. Reducing clinical variations with clinical pathways: do pathways work? Int J Qual Health Care. 2003;15(6):509–21. doi: 10.1093/intqhc/mzg057.
    1. Vanhaecht K, Bollmann M, Bower K, Gallagher C, Gardini A, Guezo J, Jansen U, Massoud R, Moody K, Sermeus W, Van Zelm RT, Whittle CL, Yazbeck AM, Zander K, Panella M. Prevalence and use of clinical pathways in 23 countries - an international survey by the European Pathway Association . J INTEGR CARE PATHWAYS. 2006;10:28–34.
    1. Bower KA. Clinical pathways: 12 lessons learned over 25 years of experience. International Journal of Care Pathways. 2009;13:78–81. doi: 10.1258/jicp.2009.009008.
    1. Panella M, Vanhaecht K. Is there still need for confusion about pathways? International Journal of Care Pathways. 2010;14:1–3. doi: 10.1258/jicp.2010.010008.
    1. Vanhaecht K, Sermeus W, Van Zelm RT, Panella M. Care Pathways are defined as complex interventions. BMC Med. 2010.
    1. Panella M, Brambilla R, Marchisio S, Di Stanislao F. Reducing stroke in-hospital mortality: organized care is a complex intervention. Stroke. 2008;39(11):e186. doi: 10.1161/STROKEAHA.108.533877.
    1. Panella M, Marchisio S, Demarchi ML, Manzoli L, Di Stanislao F. Reduced in-hospital mortality for heart failure with clinical pathways: the results of a cluster randomised controlled trial. Qual Saf Health Care. 2009;18(5):369–73. doi: 10.1136/qshc.2008.026559.
    1. Campbell M, Fitzpatrick R, Haines A, Kinmonth AL, Sandercock P, Spiegelhalter D, Tyrer P. Framework for design and evaluation of complex interventions to improve health. BMJ. 2000;321(7262):694–6. doi: 10.1136/bmj.321.7262.694.
    1. Medical Research Council. A framework for development and evaluation of RCTs for complex interventions to improve health. Medical Research Council; 2000.
    1. Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M. Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ. 2008;337:a1655. doi: 10.1136/bmj.a1655.
    1. Rotter T, Kinsman L, James E, Machotta A, Gothe H, Willis J, Snow P, Kugler J. Clinical pathways: effects on professional practice, patient outcomes, length of stay and hospital costs. Cochrane Database Syst Rev. 2010. p. CD006632.
    1. Berwick DM. The science of improvement. JAMA. 2008;299(10):1182–4. doi: 10.1001/jama.299.10.1182.
    1. Barbieri A, Vanhaecht K, Van Herck P, Sermeus W, Faggiano F, Marchisio S, Panella M. Effects of clinical pathways in the joint replacement: a meta-analysis. BMC Med. 2009;7(1):32. doi: 10.1186/1741-7015-7-32.
    1. Vanhaecht K, Sermeus W, Peers J, Deneckere S, Lodewijckx C, Leigheb F, Panella M. The European Quality of Care Pathway (EQCP) Study: history, project management & approach. International Journal of Care Pathways. 2010;14(2):52–6. doi: 10.1258/jicp.2010.010015.
    1. Seemungal TA, Hurst JR, Wedzicha JA. Exacerbation rate, health status and mortality in COPD--a review of potential interventions. Int J Chron Obstruct Pulmon Dis. 2009;4:203–23.
    1. Gold PM. The 2007 GOLD Guidelines: a comprehensive care framework. Respir Care. 2009;54(8):1040–9.
    1. Izquierdo JL, Barcina C, Jimenez J, Munoz M, Leal M. Study of the burden on patients with chronic obstructive pulmonary disease. Int J Clin Pract. 2009;63(1):87–97. doi: 10.1111/j.1742-1241.2008.01936.x.
    1. Cao Z, Ong KC, Eng P, Tan WC, Ng TP. Frequent hospital readmissions for acute exacerbation of COPD and their associated factors. Respirology. 2006;11(2):188–95. doi: 10.1111/j.1440-1843.2006.00819.x.
    1. Garcia-Aymerich J, Farrero E, Felez MA, Izquierdo J, Marrades RM, Anto JM. Risk factors of readmission to hospital for a COPD exacerbation: a prospective study. Thorax. 2003;58(2):100–5. doi: 10.1136/thorax.58.2.100.
    1. Lodewijckx C, Sermeus W, Vanhaecht K, Panella M, Deneckere S, Leigheb F, Decramer M. Inhospital management of COPD exacerbations: a systematic review of the literature with regard to adherence to international guidelines. Journal of Evaluation in Clinical Practice. 2009;15:1101–10. doi: 10.1111/j.1365-2753.2009.01305.x.
    1. Decramer M, Bartsch P, Pauwels R, Yernault JC. Management of COPD according to guidelines. A national survey among Belgian physicians. Monaldi Arch Chest Dis. 2003;59(1):62–80.
    1. McManus TE, Marley A, Kidney JC. The Mater Hospital multiprofessional care pathway for acute exacerbations of chronic obstructive pulmonary disease. J INTEGR CARE PATHWAYS. 2005;9(1):32–6.
    1. Santamaria N, Conners A, Osteraas J, Ham J, Boodram B. A prospective cohort study of the effectiveness of clinical pathways for the in-patient management of acute exacerbation of chronic obstructive pulmonary disease (COPD) Collegian. 2004;11(1):12–6.
    1. Almagro P, Barreiro B, Ochoa de EA, Quintana S, Rodriguez CM, Heredia JL, Garau J. Risk factors for hospital readmission in patients with chronic obstructive pulmonary disease. Respiration. 2006;73(3):311–7. doi: 10.1159/000088092.
    1. Groenewegen KH, Schols AM, Wouters EF. Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD. Chest. 2003;124(2):459–67. doi: 10.1378/chest.124.2.459.
    1. Panella M, Marchisio S, Gardini A, Di Stanislao F. A cluster randomized controlled trial of a clinical pathway for hospital treatment of heart failure: study design and population. BMC Health Serv Res. 2007;7:179. doi: 10.1186/1472-6963-7-179.
    1. Panella M, Marchisio S, Barbieri A, Di Stanislao F. A cluster randomized trial to assess the impact of clinical pathways for patients with stroke: rationale and design of the Clinical Pathways for Effective and Appropriate Care Study [NCT00673491] BMC Health Serv Res. 2008;8:223. doi: 10.1186/1472-6963-8-223.
    1. Celli BR, Macnee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004;23(6):932–46. doi: 10.1183/09031936.04.00014304.
    1. Rodriguez-Roisin R. COPD exacerbations.5: management. Thorax. 2006;61(6):535–44. doi: 10.1136/thx.2005.041863.
    1. Siafkas N, Wedzicha J. In: Management of chronic obstructive pulmonary disease. Siafkas N, editor. Sheffield: European Respiratory Society Ltd; 2006. Management of acute exacerbation of chronic obstructive pulmonary disease; pp. 387–400.
    1. National Institute for Clinical Excellence (NICE) Chronic obstructive pulmonary disease: national clinical guideline for management of chronic obstructive pulmonary disease in adults in primary and secondary care. Thorax. 2004;59(Suppl I):1–53.
    1. Map of Medicine. Specialist management of acute exacerbation. 2009.
    1. Farley K. The COPD critical pathway: a case study in progress. Qual Manag Health Care. 1995;3(2):43–54.
    1. Bustamante-Fermosel A, De Miguel-Yanes JM, Duffort-Falco M, Munoz J. Mortality-related factors after hospitalization for acute exacerbation of chronic obstructive pulmonary disease: the burden of clinical features. Am J Emerg Med. 2007;25(5):515–22. doi: 10.1016/j.ajem.2006.09.014.
    1. Cullen DL. Long term oxygen therapy adherence and COPD: what we don't know. Chron Respir Dis. 2006;3(4):217–22. doi: 10.1177/1479972306070506.
    1. Fink JB, Rubin BK. Problems with inhaler use: a call for improved clinician and patient education. Respir Care. 2005;50(10):1360–74.
    1. Gudmundsson G, Gislason T, Janson C, Lindberg E, Hallin R, Ulrik CS, Brondum E, Nieminen MM, Aine T, Bakke P. Risk factors for rehospitalisation in COPD: role of health status, anxiety and depression. Eur Respir J. 2005;26(3):414–9. doi: 10.1183/09031936.05.00078504.
    1. Gunen H, Hacievliyagil SS, Kosar F, Mutlu LC, Gulbas G, Pehlivan E, Sahin I, Kizkin O. Factors affecting survival of hospitalised patients with COPD. Eur Respir J. 2005;26(2):234–41. doi: 10.1183/09031936.05.00024804.
    1. Rau JL. Determinants of patient adherence to an aerosol regimen. Respir Care. 2005;50(10):1346–56.
    1. Roberts CM, Lowe D, Bucknall CE, Ryland I, Kelly Y, Pearson MG. Clinical audit indicators of outcome following admission to hospital with acute exacerbation of chronic obstructive pulmonary disease. Thorax. 2002;57(2):137–41. doi: 10.1136/thorax.57.2.137.
    1. Roberts CM, Barnes S, Lowe D, Pearson MG. Evidence for a link between mortality in acute COPD and hospital type and resources. Thorax. 2003;58(11):947–9. doi: 10.1136/thorax.58.11.947.
    1. Yohannes AM, Baldwin RC, Connolly MJ. Predictors of 1-year mortality in patients discharged from hospital following acute exacerbation of chronic obstructive pulmonary disease. Age Ageing. 2005;34(5):491–6. doi: 10.1093/ageing/afi163.
    1. Pawson R, Tilley N. Realistic Evaluation. London: SAGE Publications Ltd; 1997.
    1. Oakley A, Strange V, Bonell C, Allen E, Stephenson J. Process evaluation in randomised controlled trials of complex interventions. BMJ. 2006;332(7538):413–6. doi: 10.1136/bmj.332.7538.413.
    1. Hawe P, Shiell A, Riley T. Complex interventions: how "out of control" can a randomised controlled trial be? BMJ. 2004;328(7455):1561–3. doi: 10.1136/bmj.328.7455.1561.

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner